Nonmelanoma skin cancer tied to lower Alzheimer's risk

May 16, 2013
Nonmelanoma skin cancer tied to lower alzheimer's risk
Older individuals with nonmelanoma skin cancer seem to have a significantly reduced risk of developing Alzheimer's disease, according to a study published online May 15 in Neurology.

(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.

Robert S. White, from the College of Medicine in Bronx, N.Y., and colleagues examined the correlation of NMSC and AD using data from annual assessment for 1,102 community-residing adults (mean age, 79 years at enrollment). Correlations were examined in three nested outcomes groups: only AD (probable or possible AD as the sole diagnosis); any AD (probable AD or possible AD, as well as mixed AD/); and all-cause dementia.

The researchers found that, after adjustment for demographics, hypertension, diabetes, and , prevalent NMSC correlated with a significantly reduced risk of only AD (hazard ratio, 0.21). For 769 individuals, APOE ε4 genotypes were available. When the number of APOE ε4 alleles was included in the model the association was similar in magnitude, but was no longer significant. NMSC was not significantly associated with subsequent development of any AD or all-cause dementia.

"We deduce Alzheimer's-specific , because the effect is attenuated or eliminated when considering less-specific diagnoses such as AD with another diagnosis (any AD) or all-cause dementia," the authors write. "Further investigation is necessary to elucidate the biological and psychosocial basis for the reduced Alzheimer's risk associated with NMSC."

Several authors disclosed financial ties to the pharmaceutical and cognitive technology industries.

Explore further: Drugs targeting blood vessels may be candidates for treating Alzheimer's

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Drugs targeting blood vessels may be candidates for treating Alzheimer's

March 7, 2013
(Medical Xpress)—University of British Columbia researchers have successfully normalized the production of blood vessels in the brain of mice with Alzheimer's disease (AD) by immunizing them with amyloid beta, a protein ...

Active lifestyle associated with less Alzheimer disease-related brain change among persons with APOE epsilon4 genotype

January 16, 2012
A sedentary lifestyle is associated with greater cerebral amyloid deposition, which is characteristic of Alzheimer’s disease (AD), among cognitively normal individuals with the ε4 allele of the apolipoprotein E ...

Timing of hormone therapy use impacts alzheimer's risk

October 25, 2012
(HealthDay)—Use of hormone therapy (HT) within five years of menopause is associated with a reduction in the risk of Alzheimer's disease (AD), according to a study published online Oct. 24 in Neurology.

Another potential risk factor for developing dementia and Alzheimer's disease in women

January 2, 2012
A hormone derived from visceral fat called adiponectin may play a role as a risk factor for development of all-cause dementia and Alzheimer disease (AD) in women, according to a study published Online First by the Archives ...

Family history of Alzheimer's affects functional connectivity

May 26, 2012
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, and this effect ...

Recommended for you

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

Mice with frequent flier miles advance the Alzheimer's cause

January 4, 2018
Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.